深圳市实施消灭脊髓灰质炎策略成本效益分析

目的评价深圳市消灭脊髓灰质炎(简称脊灰)实施策略的成本投入和产出的效益,为维持无脊灰状态以及控制其他传染病提供相关依据。方法分析深圳市脊灰发病的历年资料和接种脊灰疫苗资料,采用成本-效益分析方法分析脊灰免疫的经济和社会效益。结果1978～2004年深圳市脊灰免疫投入成本为49240144元(2004年的贴现值),产出效益218671955.7元,净效益为169431811.7元,效益成本比为4.44,避免脊灰发病1349例,避免残疾270例。结论接种脊灰疫苗后可产生巨大的经济效益和社会效益,随着成本投入的降低,其效益仍将持续增长。

Objective To analyze the cost-benefit of poliomyelitis eradication polices in Sbenaben and to provide a scientific basis for maintaining the polio-free status and other disease control. Method To analyze the incidence of poliomyelitis each year from 1980 to 2004 year then cost and benefit study was used. Results Cost-benefit study analysis that discounted cost was 49 240 144 yuan from 1979 to 2004 year,production benefit was 218 671 955.7 yuan, net benefit was 169 431 811.7 yuan, ratio of cost and benefit was 4.44,social benefit analysis showed 1：349 polio cases,270 disability cases were avoided from 1979 to 2004 year. Conclusions Polio vaceination has significant economic and social benefit, and the benefits will accrue, following the global eradication of poliomyelitis and cease of cost input.